Atrial fibrillation
CCS 2020 guideline is rhythm vs rate strategy and anticoagulation.
Screening
CCS opportunistic- CCS Canadian Cardiovascular Society
| Decision | Guideline |
|---|---|
| Who | Opportunistic pulse check ≥65 CCS recommends opportunistic pulse palpation or rhythm assessment in adults ≥65.
|
Diagnose
ECG confirmation- INESSS Institut national d'excellence en santé et services sociaux
- CCS Canadian Cardiovascular Society
| Decision | Guideline |
|---|---|
| Confirm AF | ECG or rhythm strip Irregular pulse alone is not sufficient for diagnosis. INESSS 2019 GUO Fibrillation (DOAC vs warfarin) opens in a new tabCCS 2020 Atrial Fibrillation guideline hub opens in a new tab |
| Valvular AF | Mechanical valve or mod-severe MS
INESSS 2019 GUO Fibrillation (DOAC vs warfarin) opens in a new tabCCS 2020 Atrial Fibrillation guideline hub opens in a new tab |
Investigate
Stroke risk- INESSS Institut national d'excellence en santé et services sociaux
- CCS Canadian Cardiovascular Society
| Decision | Guideline |
|---|---|
| Stroke risk score | CHADS-65 or CHA₂DS₂-VASc
MDCalc CHADS-65 opens in a new tabMDCalc CHA2DS2-VASc opens in a new tabINESSS 2019 opens in a new tab |
| Bleeding risk | HAS-BLED or clinical judgment Calculate bleeding risk to identify modifiable factors, not to withhold anticoagulation.
MDCalc HAS-BLED opens in a new tabINESSS 2019 GUO Fibrillation (DOAC vs warfarin) opens in a new tabCCS 2020 Atrial Fibrillation guideline hub opens in a new tab |
| CKD and eGFR | Cockcroft-Gault for DOAC dosing Use Cockcroft-Gault equation for DOAC dose adjustment, not CKD-EPI.
INESSS 2019 opens in a new tabCCS 2020 Atrial Fibrillation guideline hub opens in a new tab |
Treat
Prefer DOAC- INESSS Institut national d'excellence en santé et services sociaux
- CCS Canadian Cardiovascular Society
| Decision | Guideline |
|---|---|
| Anticoagulation | DOAC preferred over warfarin Usual adult labeled doses below.
INESSS 2019 GUO (DOAC vs warfarin) opens in a new tabCCS 2020 AF opens in a new tab |
| Rate vs rhythm control | Rate or rhythm individualized Rate control or rhythm control selected based on symptoms, age, comorbidities.
|
| Drug | Dose | Duration |
|---|---|---|
| Apixaban | 5 mg PO BID | Ongoing |
| Rivaroxaban | 20 mg PO DIE with food | Ongoing |
| Dabigatran | 150 mg PO BID | Ongoing |
| Edoxaban | 60 mg PO DIE | Ongoing |
Special groups
Pregnancy, CKD stage 5- INESSS Institut national d'excellence en santé et services sociaux
- CCS Canadian Cardiovascular Society
| Decision | Guideline |
|---|---|
| Pregnancy | Refer No warfarin first trimester or 2–4 weeks before delivery. INESSS 2019 GUO Fibrillation (DOAC vs warfarin) opens in a new tabCCS 2020 Atrial Fibrillation guideline hub opens in a new tab |
| CKD stage 5 or dialysis | Do not routinely anticoagulate Discuss individual stroke and bleeding risks with patient and specialist. INESSS 2019 opens in a new tabCCS 2020 Atrial Fibrillation guideline hub opens in a new tab |
Reviewed 31 August 2026 against the official sources below.
Sources
Blue square: Québec · red round: Canada. The code names the body; each section's key gives its full name.